Conference Coverage
Conference Coverage
OARSI: Data further link hand osteoarthritis, cardiometabolic disease
Key clinical point: Chronic low-grade inflammation may play a role in both hand osteoarthritis and cardiometabolic disease. Major finding:...
Conference Coverage
VIDEO: Stroop app predicts hepatic encephalopathy
The Stroop App is a smartphone screening tool that tests the patient’s cognitive speed and flexibility, which physicians can administer themselves...
Conference Coverage
DDW: Scheduled for a colonoscopy? Pass the pretzels!
Conference Coverage
Reconstruction, transplantation successful for gut failure after bariatric surgery
Key clinical point: Gut failure after bariatric surgery was successfully repaired by a variety of surgical techniques in most patients. Major...
Conference Coverage
VIDEO: E-cigarettes lack long-term data for smoking cessation
Conference Coverage
DDW: HBV, tuberculosis reactivations rare in IBD patients on biologic therapy
Key clinical point: Significant clinical events related to tuberculosis and hepatitis B virus reactivation after initiating anti–tumor necrosis...
Conference Coverage
ATS: High-dose nitric oxide looks promising for infants with bronchiolitis
Key clinical point: Intermittent high-dose inhaled nitric oxide was safe and shows signals of efficacy in infants with acute bronchiolitis. Major...
Conference Coverage
VIDEO: MRI-compatible ICDs represent important advance
Conference Coverage
The GLUTOX Trial: Getting closer to identifying nonceliac gluten sensitivity
WASHINGTON – A simple dietary challenge may help identify nonceliac gluten sensitivity in patients with gastrointestinal functional disorders,...
Conference Coverage
AUA: Very low-risk prostate cancers cause few deaths over 15 years
NEW ORLEANS – Long-term active surveillance seems to be a safe and effective way to avoid overtreatment in men with low- and very low-risk...
Conference Coverage
ATS: Nintedanib found effective for IPF up to 76 weeks
The use of nintedanib 150 mg twice daily slowed disease progression in patients with idiopathic pulmonary fibrosis up to 76 weeks of treatment,...